Barely Significant
← all excerpts

Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.

Diabetes Care · 2013 · PMC3781493 · PMID 23715754

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP < 0.0001actually significant
A highly significant reduction of alkaline phosphatase levels also was observed after GFT505 treatment (effect size: −19.3%; P < 0.0001) ( Table 2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.